Education
About Us
Working with TipRanks
Follow Us
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
BCT Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BCT Stock 12 Month Forecast
Average Price Target
C$55.42
▲(229.29% Upside)
| Highest Price TargetC$55.42 | Average Price TargetC$55.42 | Lowest Price TargetC$55.42 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
C$55.42
Buy
229.29%
Upside
Reiterated
10/13/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
C$55.42
Buy
229.29%
Upside
Reiterated
10/13/25
Best Analysts Covering BriaCell Therapeutics
1 Month
xxx
Success Rate
10/28 ratings generated profit
Average Return
-10.70%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 35.71% of your transactions generating a profit, with an average return of -10.70% per trade.
3 Months
xxx
Success Rate
8/28 ratings generated profit
Average Return
-18.65%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -18.65% per trade.
1 Year
Success Rate
5/28 ratings generated profit
Average Return
-52.21%
reiterated a buy rating 2 months ago
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 17.86% of your transactions generating a profit, with an average return of -52.21% per trade.
2 Years
xxx
Success Rate
2/28 ratings generated profit
Average Return
-77.24%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.14% of your transactions generating a profit, with an average return of -77.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BCT Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
2
1
2
2
3
Buy
0
0
0
0
0
Hold
2
3
2
1
0
Sell
12
7
5
0
0
Strong Sell
0
0
0
0
0
total
16
11
9
3
3
Each month's total comprises the sum of three months' worth of ratings.
BCT Financial Forecast
BCT Stock Forecast FAQ
What is TSE:BCT’s average 12-month price target, according to analysts?
Based on analyst ratings, BriaCell Therapeutics Corp’s 12-month average price target is 55.42.
What is TSE:BCT’s upside potential, based on the analysts’ average price target?
BriaCell Therapeutics Corp has 229.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:BCT a Buy, Sell or Hold?
BriaCell Therapeutics Corp has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is BriaCell Therapeutics Corp’s price target?
The average price target for BriaCell Therapeutics Corp is 55.42. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$55.42 ,the lowest forecast is C$55.42. The average price target represents 229.29% Increase from the current price of C$16.83.
The highest analyst price target is C$55.42 ,the lowest forecast is C$55.42. The average price target represents 229.29% Increase from the current price of C$16.83.
What do analysts say about BriaCell Therapeutics Corp?
BriaCell Therapeutics Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of TSE:BCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.